RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Yourgene Health Stock

Yourgene Health ROE 2024

Yourgene Health ROE

-0.06

Ticker

YGEN.L

ISIN

GB00BN31ZD89

WKN

A116JH

In 2024, Yourgene Health's return on equity (ROE) was -0.06, a -84.19% increase from the -0.37 ROE in the previous year.

Yourgene Health Aktienanalyse

What does Yourgene Health do?

Yourgene Health PLC is an international life science company specializing in the development and marketing of DNA tests for various areas of health. The company, based in Manchester, England, was founded in 2009 and has been listed on the London Stock Exchange since 2013. The business model of Yourgene Health is to offer genetic tests for a variety of applications in order to improve people's well-being, health, and quality of life. The company has extensive experience in developing DNA diagnostic tests and offers a wide range of solutions for different markets. One of the core divisions of the company is oncology. Here, Yourgene Health PLC develops innovative test methods to identify and combat cancer cells and their growth. Another important area is reproductive health, where the company offers prenatal testing as well as fertility analysis. In Yourgene Health's broad product range, there are prenatal tests for the examination of chromosomal abnormalities in the fetus, tests for the analysis of genetic risks for hereditary diseases or thyroid diseases. The company also offers tests for the detection of bacteria and viruses, which serve as companion tests for infections. One of Yourgene Health's newest products is the Covid-19 PCR test. This test is performed through nasal and throat swabs and can provide an accurate diagnosis of coronavirus infection within a few hours. The test was developed in 2020 and has since proven to be an important measure in containing the pandemic along the test-trace-isolate model. In recent years, Yourgene Health has made numerous collaborations and acquisitions to strengthen its market position in different countries. This includes the acquisition of the US company Elucigene Diagnostics, a provider of DNA test solutions for reproductive health, in 2021. As part of its growth strategy, the company has announced expansion plans for Asia, particularly for China and Japan. For this purpose, the subsidiary Yourgene Health Shanghai was established in 2019. Yourgene Health PLC is an innovative company operating in a rapidly growing market. Through continuous development of new innovative test methods, implementation of collaborations and acquisitions, and expansion into new markets, the company is well positioned to achieve further growth successes and improve global health for consumers. Yourgene Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Yourgene Health's Return on Equity (ROE)

Yourgene Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Yourgene Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Yourgene Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Yourgene Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Yourgene Health stock

What is the ROE (Return on Equity) of Yourgene Health this year?

The ROE of Yourgene Health this year is -0.06 undefined.

How has the Return on Equity (ROE) of Yourgene Health developed compared to the previous year?

The ROE of Yourgene Health has increased by -84.19% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Yourgene Health?

A high ROE indicates that Yourgene Health generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Yourgene Health?

A low ROE can indicate that Yourgene Health is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Yourgene Health affect the company?

A change in ROE (Return on Equity) of Yourgene Health can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Yourgene Health?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Yourgene Health?

Some factors that can influence Yourgene Health's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Yourgene Health pay?

Over the past 12 months, Yourgene Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Yourgene Health is expected to pay a dividend of 0 GBP.

What is the dividend yield of Yourgene Health?

The current dividend yield of Yourgene Health is .

When does Yourgene Health pay dividends?

Yourgene Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Yourgene Health?

Yourgene Health paid dividends every year for the past 0 years.

What is the dividend of Yourgene Health?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Yourgene Health located?

Yourgene Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Yourgene Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Yourgene Health from 10/2/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Yourgene Health pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Yourgene Health in the year 2023?

In the year 2023, Yourgene Health distributed 0 GBP as dividends.

In which currency does Yourgene Health pay out the dividend?

The dividends of Yourgene Health are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Yourgene Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Yourgene Health

Our stock analysis for Yourgene Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yourgene Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.